Skip to content

Amprius Technologies AMPX Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Eos Energy Enterprises, Inc. logo
Eos Energy Enterprises, Inc.EOSE
Wolfspeed logo
WolfspeedWOLF
EnerSys logo
EnerSysENS
Albemarle logo
AlbemarleALB
Enphase Energy logo
Enphase EnergyENPH

Other financials

Income statement

See full
Revenue$28.5M+153%
Gross profit$5.7M+343%
Operating income-$6.7M+30.9%
Net income-$5.0M+46.2%
EPS (diluted)-$0.04+50.0%

Balance sheet

See full
Cash & equivalents$62.6M+25.5%
Total debt$6.6M-82.6%
Total equity$109.4M+55.4%
Total assets$130.8M+10.4%

Cash flow

See full
Operating cash flow-$37.3M-164%
CapEx$980.0K+7.3%
Free cash flow-$38.3M-154%

Valuation

See full
Market cap$1.77B+631%

Profitability

See full
Gross margin18.1%+10.5pp
Operating margin-48.4%-19.0pp
Net margin-44%-17.6pp
FCF margin-65.1%-19.6pp

Returns & leverage

See full
Return on equity-44.2%-11.4pp
Debt / equity0.1×-0.5×
Current ratio7.1×+2.4×

Where this comes from

Reported directly by Amprius Technologies in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Amprius Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amprius Technologies's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amprius Technologies's common stock, shares authorized (in shares)?
Amprius Technologies (AMPX) reported common stock, shares authorized (in shares) of $950M in Q1 2026.
How has Amprius Technologies's common stock, shares authorized (in shares) changed year-over-year?
Amprius Technologies's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $950M to $950M.
What is the long-term trend for Amprius Technologies's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Amprius Technologies's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $950M to $950M.